Gotowe bibliografie tematyczne / Coronary heart disease Molecular aspects

Spis treści

  1. Artykuły w czasopismach
  2. Rozprawy doktorskie
  3. Książki
  4. Części książek
  5. Streszczenia konferencji

Gotowa bibliografia na temat „Coronary heart disease Molecular aspects”

Autor: Grafiati
Data publikacji: 4 czerwca 2021
Data aktualizacji: 1 lutego 2022

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Coronary heart disease Molecular aspects”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Artykuły w czasopismach na temat "Coronary heart disease Molecular aspects"

1

Pries, Axel R., Wolfgang M. Kuebler, and Helmut Habazettl. "Coronary Microcirculation in Ischemic Heart Disease." Current Pharmaceutical Design 24, no. 25 (November 8, 2018): 2893–99. http://dx.doi.org/10.2174/1381612824666180625142341.

Pełny tekst źródła
Streszczenie:
Background: Ischemic heart disease has long been considered to be exlusively caused by stenosis or occlusion. However, the coronary microcirculation too may play an important role in ischemic conditions. Also, the crucial role of microvessels in not only regulating blood flow on a local level but also mediating vascular permeability or inflammatory responses has been recognized. Objective: To review important physiological and pathophysiological mechanisms of coronary microcirculatory control with focus on heterogeneity of local perfusion, microvascular permeability and inflammation. Method: S
Style APA, Harvard, Vancouver, ISO itp.
2

Cavarretta, Elena, and Giacomo Frati. "MicroRNAs in Coronary Heart Disease: Ready to Enter the Clinical Arena?" BioMed Research International 2016 (2016): 1–10. http://dx.doi.org/10.1155/2016/2150763.

Pełny tekst źródła
Streszczenie:
Coronary artery disease (CAD) and its complication remain the leading cause of mortality in industrialized countries despite great advances in terms of diagnosis, prognosis, and treatment options. MicroRNAs (miRNAs), small noncoding RNAs, act as posttranscriptional gene expression modulators and have been implicated as key regulators in several physiological and pathological processes linked to CAD. Circulating miRNAs have been evaluated as promising novel biomarkers of CAD, acute coronary syndromes, and acute myocardial infarction, with prognostic implications. Several challenges related to t
Style APA, Harvard, Vancouver, ISO itp.
3

Santosa Putra, Iwan Cahyo, and William Kamarullah. "Diving deep into chelation therapy for coronary artery disease: a review." International Journal of Basic & Clinical Pharmacology 8, no. 12 (November 25, 2019): 2769. http://dx.doi.org/10.18203/2319-2003.ijbcp20195295.

Pełny tekst źródła
Streszczenie:
Chelation therapy is still a mainstay therapy when it comes to dealing with heavy metal intoxication. The ability of various chelators to bind metal and other chemical molecules led to the idea whether chelation therapy can be used as an alternative therapy to enchain calcium element that is known to be present in the atherosclerotic plaque. Various studies have been conducted, one of which is a large trial to assess chelation therapy study to show in case ethylenediaminetetraacetic acid (EDTA) chelator can be proven by evidence-based in managing coronary heart disease. Despite the favorable r
Style APA, Harvard, Vancouver, ISO itp.
4

Khaw, Kay-Tee. "Epidemiological aspects of ageing." Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences 352, no. 1363 (December 29, 1997): 1829–35. http://dx.doi.org/10.1098/rstb.1997.0168.

Pełny tekst źródła
Streszczenie:
A major societal challenge is to improve quality of life and prevent or reduce disability and dependency in an ageing population. Increasing age is associated with increasing risk of disability and loss of independence, due to functional impairments such as loss of mobility, hearing and vision; a major issue must be how far disability can be prevented. Ageing is associated with loss of bone tissue, reduction in muscle mass, reduced respiratory function, decline in cognitive function, rise in blood pressure and macular degeneration which predispose to disabling conditions such as osteoporosis,
Style APA, Harvard, Vancouver, ISO itp.
5

Malekmohammad, Khojasteh, Robert D. E. Sewell, and Mahmoud Rafieian-Kopaei. "Antioxidants and Atherosclerosis: Mechanistic Aspects." Biomolecules 9, no. 8 (July 25, 2019): 301. http://dx.doi.org/10.3390/biom9080301.

Pełny tekst źródła
Streszczenie:
Atherosclerosis is a chronic inflammatory disease which is a major cause of coronary heart disease and stroke in humans. It is characterized by intimal plaques and cholesterol accumulation in arterial walls. The side effects of currently prescribed synthetic drugs and their high cost in the treatment of atherosclerosis has prompted the use of alternative herbal medicines, dietary supplements, and antioxidants associated with fewer adverse effects for the treatment of atherosclerosis. This article aims to present the activity mechanisms of antioxidants on atherosclerosis along with a review of
Style APA, Harvard, Vancouver, ISO itp.
6

Simmonds, Steven J., Ilona Cuijpers, Stephane Heymans, and Elizabeth A. V. Jones. "Cellular and Molecular Differences between HFpEF and HFrEF: A Step Ahead in an Improved Pathological Understanding." Cells 9, no. 1 (January 18, 2020): 242. http://dx.doi.org/10.3390/cells9010242.

Pełny tekst źródła
Streszczenie:
Heart failure (HF) is the most rapidly growing cardiovascular health burden worldwide. HF can be classified into three groups based on the percentage of the ejection fraction (EF): heart failure with reduced EF (HFrEF), heart failure with mid-range—also called mildly reduced EF— (HFmrEF), and heart failure with preserved ejection fraction (HFpEF). HFmrEF can progress into either HFrEF or HFpEF, but its phenotype is dominated by coronary artery disease, as in HFrEF. HFrEF and HFpEF present with differences in both the development and progression of the disease secondary to changes at the cellul
Style APA, Harvard, Vancouver, ISO itp.
7

Golukhova, E. Z., O. I. Gromova, R. A. Shomahov, N. I. Bulaeva, and L. A. Bockeria. "Monogenec Arrhythmic Syndromes: From Molecular and Genetic Aspects to Bedside." Acta Naturae 8, no. 2 (June 15, 2016): 62–74. http://dx.doi.org/10.32607/20758251-2016-8-2-62-74.

Pełny tekst źródła
Streszczenie:
The abrupt cessation of effective cardiac function that is generally due to heart rhythm disorders can cause sudden and unexpected death at any age and is referred to as a syndrome called sudden cardiac death (SCD). Annually, about 400,000 cases of SCD occur in the United States alone. Less than 5% of the resuscitation techniques are effective. The prevalence of SCD in a population rises with age according to the prevalence of coronary artery disease, which is the most common cause of sudden cardiac arrest. However, there is a peak in SCD incidence for the age below 5 years, which is equal to
Style APA, Harvard, Vancouver, ISO itp.
8

Bastos, Marcelo B., Maarten P. van Wiechen, and Nicolas M. Van Mieghem. "PulseCath iVAC2L: next-generation pulsatile mechanical circulatory support." Future Cardiology 16, no. 2 (March 2020): 103–12. http://dx.doi.org/10.2217/fca-2019-0060.

Pełny tekst źródła
Streszczenie:
Contemporary state of the art percutaneous coronary intervention techniques offer treatment strategies and solutions to an increasing number of patients with heart failure and complex coronary artery disease. Percutaneous mechanical circulatory support is intended to alleviate the mechanical and energetic workload imposed to a failing ventricle by reducing left ventricle pressures and volumes and potentially also increasing coronary blood flow. The PulseCath iVAC2L is a transaortic left ventricular assist device that applies a pneumatic driving system to produce pulsatile forward flow. Herein,
Style APA, Harvard, Vancouver, ISO itp.
9

Ventegodt, Søren, Efrat Merrick, and Joav Merrick. "Clinical Holistic Medicine: The Dean Ornish Program (“Opening the Heart”) in Cardiovascular Disease." Scientific World JOURNAL 6 (2006): 1977–84. http://dx.doi.org/10.1100/tsw.2006.330.

Pełny tekst źródła
Streszczenie:
Dean Ornish of the Preventive Medicine Research Institute in Sausalito, California has created an intensive holistic treatment for coronary heart patients with improved diet (low fat, whole foods, plant based), exercise, stress management, and social support that has proven to be efficient. In this paper, we analyze the rationale behind his cure in relation to contemporary holistic medical theory. In spite of a complex treatment program, the principles seem to be simple and in accordance with holistic medical theories, like the Antonovsky concept of rehabilitating the sense of coherence and th
Style APA, Harvard, Vancouver, ISO itp.
10

Shi, Qi, Kuo Gao, Huihui Zhao, Juan Wang, Xing Zhai, Peng Lu, Jianxin Chen, and Wei Wang. "Phenomics Research on Coronary Heart Disease Based on Human Phenotype Ontology." BioMed Research International 2014 (2014): 1–16. http://dx.doi.org/10.1155/2014/240284.

Pełny tekst źródła
Streszczenie:
The characteristics of holistic, dynamics, complexity, and spatial and temporal features enable “Omics” and theories of TCM to interlink with each other. HPO, namely, “characterization,” can be understood as a sorting and generalization of the manifestations shown by people with diseases on the basis of the phenomics. Syndrome is the overall “manifestation” of human body pathological and physiological changes expressed by four diagnostic methods’ information. The four diagnostic methods’ data could be the most objective and direct manifestations of human body under morbid conditions. In this a
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Rozprawy doktorskie na temat "Coronary heart disease Molecular aspects"

1

Warner, Anke Sigrid. "The expression, regulation and effects of inducible nitric oxide synthase in hibernating myocardium." Title page, contents and summary only, 2002. http://web4.library.adelaide.edu.au/theses/09PH/09phw279.pdf.

Pełny tekst źródła
Streszczenie:
Amendments inserted at back. "May 2002" Includes bibliographical references (leaves 237-290) Experiments described in this thesis address the potential role of inducible nitric oxide synthase (iNOS) in hibernating myocardium. Specifically it was sought to establish a cellular model of hibernating myocardium and investigate the expression, regulation and effects of iNOS in this model. Experiments were performed using primary cultures of neonatal rat ventricular myocytes.
Style APA, Harvard, Vancouver, ISO itp.
2

Makubalo, Zola. "Mutation screening of candidate genes and the development of polymorphic markers residing on chromosome 19q13.3, the progressive familial heart block I gene search area." Thesis, Stellenbosch : Stellenbosch University, 2000. http://hdl.handle.net/10019.1/51838.

Pełny tekst źródła
Streszczenie:
Thesis (MSc)--Stellenbosch University, 2000.<br>ENGLISH ABSTRACT: Progressive familial heart block type I (PFHBI) is a cardiac ventricular conduction disorder of unknown cause associated with risk of sudden death, which has been described in several South African families. Clinically, PFHBI is characterised by right bundle branch block on ECG, which may progress to complete heart block, necessitating pacemaker implantation. The disease shows an autosomal dominant pattern of inheritance with evidence of genetic anticipation. Using genetic linkage analysis, the PFHBI-causative gene was map
Style APA, Harvard, Vancouver, ISO itp.
3

Sarwar, Nadeem. "Emerging molecular and genetic risk factors for coronary heart disease." Thesis, University of Cambridge, 2009. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.611549.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Ashton, Emma Louise, and emma ashton@deakin edu au. "Effects of dietary constituents on coronary heart disease risk factors." Deakin University. School of Biological and Chemical Sciences, 2000. http://tux.lib.deakin.edu.au./adt-VDU/public/adt-VDU20061207.153511.

Pełny tekst źródła
Streszczenie:
Coronary Heart Disease (CHD) is a major cause of death in Western countries. Mediterranean and Asian populations have a lower risk of death from CHD compared to Westernised population, as do vegetarian versus omnivorous populations. Dietary constituents of traditional diets consumed by these populations are thought to influence both the classical risk factors for CHD, and the more recently identified risk factors, such as oxidative modification of low density lipoprotein (LDL), LDL particle size, arterial compliance and haemostatic factors. The aim of this thesis was to examine the effects
Style APA, Harvard, Vancouver, ISO itp.
5

Abdul-Majid, Hariyati Shahrima. "Psychological aspects of recovery from coronary heart disease among patients in Malaysia." Thesis, University of Surrey, 2001. http://epubs.surrey.ac.uk/843015/.

Pełny tekst źródła
Streszczenie:
The aim of this research was to identify psychological factors associated with outcomes of coronary heart disease (CHD) among patients in Malaysia. The research tested whether a model of psychological factors found to predict recovery from CHD in the West would be applicable in a collectivistic society such as Malaysia. Among the research questions posed were whether self-referent beliefs, coping styles and locus of control constructs would predict affective status for patients at the time of hospitalisation, and whether these psychological constructs would predict patients' affective status,
Style APA, Harvard, Vancouver, ISO itp.
6

Ho, Lai-yi Ada, and 何麗儀. "Does social support influence coronary heart disease prognosis?: a meta-analysis." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2005. http://hub.hku.hk/bib/B39724116.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Jenneke, Cindy A. N. "The effect of dietary patterns on risk factors for CHD : a comparative study of students residing at the Adventist International Institute of Advanced Studies in the Philippines." Thesis, Link to online version, 2006. http://hdl.handle.net/10019/554.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Cao, Fei. "Chlamydia pneumoniae, toll-like receptors and pathogenesis of atherosclerotic heart disease." View the abstract Download the full-text PDF version (on campus access only), 2007. http://etd.utmem.edu/ABSTRACTS/2007-022-Cao-index.html.

Pełny tekst źródła
Streszczenie:
Thesis (Ph.D. )--University of Tennessee Health Science Center, 2007.<br>Title from title page screen (viewed on May 16, 2008 ). Research advisor: Gerald I. Byrne, Ph.D. Document formatted into pages (xi, 114 p. : ill.). Vita. Abstract. Includes bibliographical references (p. 65-107).
Style APA, Harvard, Vancouver, ISO itp.
9

Buri, Robert J. (Robert John). "The Role of Anger/Hostility on Physiological and Behavioral Risk Factors for Coronary Heart Disease." Thesis, University of North Texas, 1995. https://digital.library.unt.edu/ark:/67531/metadc278222/.

Pełny tekst źródła
Streszczenie:
The purpose of this study was to examine the role of anger/hostility on physiological and behavioral coronary heart disease risk factors. It was hypothesized that anger/hostility would contribute to the severity of CHD via consummatory behaviors such as smoking, poor diet, and excessive alcohol consumption. Some researchers suggest that negative consummatory behaviors play a direct causal role in CHD. The present study proposed that hostility predisposes an individual to these behaviors, and that these behaviors in turn, contribute to CHD. Further, it was proposed that some of the anger that e
Style APA, Harvard, Vancouver, ISO itp.
10

Pepe, Salvatore. "The influence of dietary fatty acids on cardiac function /." Title page, table of contents and abstract only, 1991. http://web4.library.adelaide.edu.au/theses/09PH/09php4201.pdf.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Książki na temat "Coronary heart disease Molecular aspects"

1

Vlodaver, Zeev. Coronary Heart Disease: Clinical, Pathological, Imaging, and Molecular Profiles. Boston, MA: Springer US, 2012.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

S, Leon Arthur, ed. Coronary heart disease: A behavorial perspective. Champaign, Ill: Research Press, 1992.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Budnick, Herbert N. Heart to heart: A guide to the psychological aspects of heart disease. Santa Fe, NM: Health Press, 1991.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Thompson, David R. Counselling the coronary patient and partner. Harrow: Scutari Press, 1990.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Kris-Etherton, P. M. Trans fatty acids and coronary heart disease risk. Washington, D.C: ILSI Press, 1995.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Mogadam, Michael. Choosing foods for a healthy heart. Yonkers, N.Y: Consumer Reports Books, 1993.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Mangiapane, E. H. Diet, lipoproteins and coronary heart disease: A biochemical perspective. Nottingham: Nottingham University Press, 1998.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

1919-, Hallgren Bo, and Svenska läkaresällskapet, eds. Diet and prevention of coronary heart disease and cancer. New York: Raven Press, 1986.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Healthy heart handbook: How to prevent and reverse heart disease ... Makaha, Hawaii: Healing Heart Foundation, 1994.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Friedman, Meyer. Treating type A behavior and your heart. New York: Fawcett Crest, 1985.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Części książek na temat "Coronary heart disease Molecular aspects"

1

Lemmer, Björn, and Klaus Witte. "Chronopharmacological aspects of coronary heart disease." In Developments in Cardiovascular Medicine, 295–308. Dordrecht: Springer Netherlands, 1996. http://dx.doi.org/10.1007/978-94-009-1577-0_19.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Galton, David J. "Molecular Genetics of Coronary Heart Disease." In Advances in Experimental Medicine and Biology, 95–105. Boston, MA: Springer US, 1988. http://dx.doi.org/10.1007/978-1-4613-0733-4_13.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Assmann, G., A. von Eckardstein, and H. Funke. "Apolipoproteins, Reverse Cholesterol Transport and Coronary Heart Disease." In Cellular and Molecular Biology of Atherosclerosis, 159–66. London: Springer London, 1992. http://dx.doi.org/10.1007/978-1-4471-1909-8_15.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Heusch, Gerd, and B. D. Guth. "New aspects on the pathophysiology of coronary heart disease." In Treatment with Gallopamil, 65–84. Heidelberg: Steinkopff, 1989. http://dx.doi.org/10.1007/978-3-642-85376-0_7.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Patsch, J. R., and G. Miesenboeck. "High-Density Lipoprotein Cholesterol, Triglycerides and Coronary Heart Disease." In Cellular and Molecular Biology of Atherosclerosis, 153–57. London: Springer London, 1992. http://dx.doi.org/10.1007/978-1-4471-1909-8_14.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Soubrier, F., X. Jeunemaître, B. Rigat, F. Cambien, and P. Corvol. "Molecular Genetics and Familial Arterial Hypertension." In Genetic Approaches to Coronary Heart Disease and Hypertension, 27–37. Berlin, Heidelberg: Springer Berlin Heidelberg, 1991. http://dx.doi.org/10.1007/978-3-642-76891-0_4.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Calabresi, Laura, and Guido Francheschini. "Genetic LCAT Deficiency: Molecular Diagnosis, Plasma Lipids, and Atherosclerosis." In High Density Lipoproteins, Dyslipidemia, and Coronary Heart Disease, 89–93. New York, NY: Springer New York, 2010. http://dx.doi.org/10.1007/978-1-4419-1059-2_11.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Berg, Kåre. "Genetics of Coronary Heart Disease and its Risk Factors." In Ciba Foundation Symposium 130 - Molecular Approaches to Human Polygenic Disease, 14–33. Chichester, UK: John Wiley & Sons, Ltd., 2007. http://dx.doi.org/10.1002/9780470513507.ch3.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

ter Keurs, Henk E. D. J. "Macroscopic and Microscopic Aspects of Cardiac Dysfunction in Congestive Heart Failure." In Molecular Defects in Cardiovascular Disease, 95–107. New York, NY: Springer New York, 2011. http://dx.doi.org/10.1007/978-1-4419-7130-2_8.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Inagaki, Tadakatsu, Hirotsugu Tsuchimochi, James T. Pearson, Daryl O. Schwenke, Keiji Umetani, Mikiyasu Shirai, and Yoshikazu Nakaoka. "Impaired Right Coronary Vasodilator Function in Pulmonary Hypertensive Rats Assessed by In Vivo Synchrotron Microangiography." In Molecular Mechanism of Congenital Heart Disease and Pulmonary Hypertension, 193–95. Singapore: Springer Singapore, 2020. http://dx.doi.org/10.1007/978-981-15-1185-1_25.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Streszczenia konferencji na temat "Coronary heart disease Molecular aspects"

1

Tao, Weiye, Laiyou Wang, Guohua Cheng, Jun Liu, and Langping Tang. "Mechanism of Sini Decoction on Coronary Heart Disease in Molecular Level." In 2nd International Conference on Computer and Information Applications (ICCIA 2012). Paris, France: Atlantis Press, 2012. http://dx.doi.org/10.2991/iccia.2012.144.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Uzbekova, Nelly, Sergey Kityan, and Nodira Badalbaeva. "USE OF PLETHYSMOGRAPHY IN THE ASSESSMENT OF THE ARTERIAL WALL IN PERSONS WITH CORONARY HEART DISEASE." In THEORETICAL AND PRACTICAL ASPECTS OF MODERN SCIENTIFIC RESEARCH. European Scientific Platform, 2021. http://dx.doi.org/10.36074/logos-30.04.2021.v2.43.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Falk, E. A. "UNSTABLE ANGINA PECTORIS: PATHOLOGIC ASPECTS." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643711.

Pełny tekst źródła
Streszczenie:
Unstable angina pectoris represents a common and important manifestation of acute ischemic heart disease encompassing the broad spectrum of clinical syndromes between stable effort angina and acute myocardial infarction. This group of patientsisfar from uniform concerning underlying pathogenetic mechanisms and prognosis, but generally the risk of infarction or deathis increased during the unstable period. Most patients are presenting with new or worsening effort angina or angina at rest,and especially patients with rest anginaassociated with transient ECG changes seem to constitute a high risk
Style APA, Harvard, Vancouver, ISO itp.
4

Denisova, Tatyana P., Lidia I. Malinova, and Igor A. Malinov. "Physical and mathematical aspects of blood-glucose- and insulin-level kinetics in patients with coronary heart disease and high risk of its development." In Saratov Fall Meeting 2000, edited by Valery V. Tuchin. SPIE, 2001. http://dx.doi.org/10.1117/12.431540.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Zhang, Song, John A. Crow, Robert C. Cooper, Ronald M. McLaughlin, Shane Burgess, Ali Borazjani, and Jun Liao. "Detection of Myocardial Fiber Disruption in Artificial Lesions With 3D DT-MRI Tract Models." In ASME 2008 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2008. http://dx.doi.org/10.1115/sbc2008-193121.

Pełny tekst źródła
Streszczenie:
In the United States, it is estimated that in 2008 approximately 1.2 million people will suffer a new or recurrent myocardial infarction. In 2005, the latest full year for which statistics are available, 16 million Americans (7.3% of the population) had some form of coronary heart disease. Loss of myocardium as a result of myocardial infarction increases wall stress locally and globally and triggers adaptive responses at the molecular, cellular, and tissue levels. These adaptive responses can lead to left ventricular dilation and congestive heart failure. Accurate non-invasive evaluation of my
Style APA, Harvard, Vancouver, ISO itp.
6

Poniewierski, M., M. Barthels, and H. Poliwoda. "THE SAFETY AND EFFICACY OF A LOW MOLECULAR WEIGHT HEPARIN (FRAGMIN) IN THE PREVENTION OF DEEP VEIN THROMBOSIS IN MEDICAL PATIENTS: A RANDOMIZED DOUBLE-BLIND TRIAL." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643224.

Pełny tekst źródła
Streszczenie:
The safety and efficacy of 2500 anti-Factor Xa U of a low molecular weight heparin (Kabi 2165, Fragmin) subcutaneously once a day, and 5000 IU of standard unfractionated Heparin (KabiVitrum, Stockholm) subcutaneously twice daily as thromboprophylaxis was compared in 200 medical patients in a randomized double blind trial. According to the risk of DVT the patients were stratified before randomization in a high and low risk group. The high risk group consisted of 100 patients mainly with malignant diseases and/or previous history of thromboembolism, the low risk group of 100 patients with mainly
Style APA, Harvard, Vancouver, ISO itp.
Możesz być także zainteresowany rozszerzonymi bibliografiami na temat „Coronary heart disease Molecular aspects” dla poszczególnych typów źródeł:
Artykuły w czasopismach Rozprawy doktorskie Książki
Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!

Do bibliografii